Clinical outcomes: In the STEP 1 clinical trial, participants using semaglutide 2.4 mg (Wegovy) lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group
Subcutaneous bioavailability is nearly complete thanks to albumin binding conferred by the C20 chain
For providers, its a way to learn how to identify and address the earliest indicators of aging.* EXPERIENCING HORMONE IMBALANCE
All doses of Wegovy cost $499
Always discuss your history, current medications, and conditions with your healthcare provider before initiating therapy
Originally, its use was limited to treating children with a complete deficiency of this hormone, and until the mid-1980s, it was obtained from the pituitary glands of cadavers ( Although these preparations were biologically active, their production was limited due to the scarcity of this natural source